Temprana CF - Search Results

1

PAMAM dendrimers as a carbamazepine delivery system for neurodegenerative diseases: A biophysical and nanotoxicological characterization.

Igartúa DE, Martinez CS, Temprana CF, Alonso SDV, Prieto MJ. Igartúa DE, et al. Among authors: temprana cf. Int J Pharm. 2018 Jun 10;544(1):191-202. doi: 10.1016/j.ijpharm.2018.04.032. Epub 2018 Apr 17. Int J Pharm. 2018. PMID: 29678547

2

Optimization and in vitro toxicity evaluation of G4 PAMAM dendrimer-risperidone complexes.

Prieto MJ, Temprana CF, del Río Zabala NE, Marotta CH, Alonso Sdel V. Prieto MJ, et al. Among authors: temprana cf. Eur J Med Chem. 2011 Mar;46(3):845-50. doi: 10.1016/j.ejmech.2010.12.021. Epub 2010 Dec 22. Eur J Med Chem. 2011. PMID: 21251731

3

Nano-formulation for topical treatment of precancerous lesions: skin penetration, in vitro, and in vivo toxicological evaluation.

Calienni MN, Temprana CF, Prieto MJ, Paolino D, Fresta M, Tekinay AB, Alonso SDV, Montanari J. Calienni MN, et al. Among authors: temprana cf. Drug Deliv Transl Res. 2018 Jun;8(3):496-514. doi: 10.1007/s13346-017-0469-1. Drug Deliv Transl Res. 2018. PMID: 29288359

4

Diacetylenic lipids in the design of stable lipopolymers able to complex and protect plasmid DNA.

Temprana CF, Prieto MJ, Igartúa DE, Femia AL, Amor MS, Alonso SDV. Temprana CF, et al. PLoS One. 2017 Oct 11;12(10):e0186194. doi: 10.1371/journal.pone.0186194. eCollection 2017. PLoS One. 2017. PMID: 29020107 Free PMC article.

5

The Topical Nanodelivery of Vismodegib Enhances Its Skin Penetration and Performance In Vitro While Reducing Its Toxicity In Vivo.

Calienni MN, Maza Vega D, Temprana CF, Izquierdo MC, Ybarra DE, Bernabeu E, Moretton M, Alvira FC, Chiappetta D, Alonso SDV, Prieto MJ, Montanari J. Calienni MN, et al. Among authors: temprana cf. Pharmaceutics. 2021 Feb 1;13(2):186. doi: 10.3390/pharmaceutics13020186. Pharmaceutics. 2021. PMID: 33535434 Free PMC article.

6

Structural effect of cationic amphiphiles in diacetylenic photopolymerizable membranes.

Temprana CF, Duarte EL, Femia AL, Alonso Sdel V, Lamy MT. Temprana CF, et al. Chem Phys Lipids. 2012 Jul;165(5):589-600. doi: 10.1016/j.chemphyslip.2012.06.007. Epub 2012 Jul 4. Chem Phys Lipids. 2012. PMID: 22771924 Free article.

7

Synthesis of a fluorescently labeled compound for the detection of arsenic-induced apoptotic HL60 cells.

Femia AL, Temprana CF, Amor MS, Grasselli M, Alonso Sdel V. Femia AL, et al. Among authors: temprana cf. Med Chem. 2012 Mar;8(2):222-9. doi: 10.2174/157340612800493584. Med Chem. 2012. PMID: 22385172

8

An arsenic fluorescent compound as a novel probe to study arsenic-binding proteins.

Femia AL, Temprana CF, Santos J, Carbajal ML, Amor MS, Grasselli M, Alonso Sdel V. Femia AL, et al. Among authors: temprana cf. Protein J. 2012 Dec;31(8):656-66. doi: 10.1007/s10930-012-9441-6. Protein J. 2012. PMID: 22936492

9

Ultraviolet irradiation of diacetylenic liposomes as a strategy to improve size stability and to alter protein binding without cytotoxicity enhancement.

Temprana CF, Amor MS, Femia AL, Gasparri J, Taira MC, del Valle Alonso S. Temprana CF, et al. J Liposome Res. 2011 Jun;21(2):141-50. doi: 10.3109/08982104.2010.492477. Epub 2010 Jun 18. J Liposome Res. 2011. PMID: 20560742

10

Evaluation of the immunogenicity of a recombinant HSV-1 vector expressing human group C rotavirus VP6 protein.

Rota RP, Palacios CA, Temprana CF, Argüelles MH, Mandile MG, Mattion N, Laimbacher AS, Fraefel C, Castello AA, Glikmann G. Rota RP, et al. Among authors: temprana cf. J Virol Methods. 2018 Jun;256:24-31. doi: 10.1016/j.jviromet.2018.02.020. Epub 2018 Feb 27. J Virol Methods. 2018. PMID: 29496429

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters